Delivery Order SPE2DB24D1007-SPE2DB25FCCLB
- Not listed
- The U.S. Defense Department's Medical Supply Chain awarded a $17,099.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Vemlidy 25mg tablets (30-count units) on September 9, 2025, with an ultimate completion date of October 6, 2025. The order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,873.72 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-unit package) on September 8, 2025, with an ultimate completion date of September 9, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime contract...
- The Defense Logistics Agency awarded a $8,586.21 firm fixed price delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on September 22, 2025, with an ultimate completion date of September 23, 2025. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's Corporate...
- The Defense Logistics Agency awarded a $7,426.36 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Vemlidy 25 mg on November 4, 2025, with completion scheduled for November 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a single delivery order under AmerisourceBergen's existing pharmaceutical supply agreement with DLA. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a delivery order valued at $4,700.52 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract for pharmaceutical supply to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at approximately $13,969 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on September 18, 2025, with an ultimate completion date of September 19, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement executed under AmerisourceBergen's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The performance location is AmerisourceBergen's...
- The Defense Logistics Agency awarded a $5,870.73 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) with an ultimate completion date of October 20, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $10,560.80 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $2,981.76 delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on July 22, 2025, with a completion date of July 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be fulfilled at the vendor's Conshohocken, Pennsylvania location. The delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $5,638.58 firm fixed price delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical supply vehicle running through December 2026. The delivery order will be fulfilled from the vendor's...
- SPE2DB24D1007Indefinite Delivery Contract
- SPE2DB24D1007-SPE2DB25FCCLBDelivery Order
The Defense Logistics Agency awarded a $9,945.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on July 10, 2025, with completion scheduled for July 11, 2025. This non-set-aside competitive award is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply an extensive range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement needs, particularly for military and veteran healthcare systems, through its extensive portfolio of pharmaceutical products and medical supplies. The company holds a significant position as a prime vendor under the DLA Medical Supply Chain, fulfilling requirements across multiple therapeutic domains. This specific delivery order for Vemlidy—an antiviral medication—exemplifies the company's role in supporting the Defense Health Agency and other government healthcare systems with specialized pharmaceutical products needed for active military personnel, retirees, and other eligible beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.9k | 7/10/25 |